alleging they illegally drove up drug prices. Apart from pharmacy benefit managers, the FTC says Eli Lilly, Sanofi and Novo Nordisk have control over the insulin market, and all three companies ...

(AP) - The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin ... the drug prices. The FTC said the ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

The FTC believes that the PBMs participated in unjust competition and practices, incentivizing manufacturers to increase insulin list prices. “Express Scripts intends to vigorously defend itself to ...

The FTC has been investigating PBMs and their role in insulin prices since 2022. The agency's lawsuit argues that the three PBMs have created a "perverse" system that prioritizes high rebates from ...

The FTC suit accuses CVS Health's Caremark, UnitedHealth's Optum, and Cigna's Express Scripts of unfairly limiting access to insulin drugs with lower list prices and steering patients toward more ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

The FTC alleges that these companies engaged in anticompetitive and unfair rebating practices that have artificially inflated the list prices of insulin drugs, restricted patient access to lower ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin ... off the drug prices. The FTC said the ...